Pharmacokinetics of lithium in plasma and red blood cells in acute and chronic intoxicated patients. 1995

G Ferron, and M Debray, and F Buneaux, and F J Baud, and J M Scherrmann
Département de Pharmacocinétique et Biomathématiques, Université Paris V, France.

Lithium disposition in plasma, red blood cells (RBC) and urine was studied in acute self-poisoned patients upon chronic lithium therapy (n = 4) and in chronic intoxicated patients receiving oral lithium (n = 10). Following acute intoxication upon chronic lithium therapy, lithium pharmacokinetics did not differ from previous reports. Terminal plasma half-life ranged from 19.0-29.0 h and RBC/plasma ratio was 0.32 +/- 0.11. The distribution volume of the terminal phase, Vz, was estimated at 0.84 +/- 0.32 l/kg and renal clearance was 0.38 +/- 0.11 ml/mn/kg. After chronic intoxication lithium pharmacokinetics differed from those of the acute patients. Terminal plasma half-life ranged from 36.5-79.4 h and zero-order decline appeared in 8 of the 10 patients. The RBC/plasma ratio was 0.87 +/- 0.22 on admission. Vz was estimated at 0.71 +/- 0.27 l/kg and renal clearance was 0.16 +/- 0.07 ml/mn/kg. These modifications in lithium elimination kinetics could be related to the decrease in the glomerular filtration rate with age or renal dysfunction in this group of patients.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive

Related Publications

G Ferron, and M Debray, and F Buneaux, and F J Baud, and J M Scherrmann
July 1978, Acta psychiatrica Scandinavica,
G Ferron, and M Debray, and F Buneaux, and F J Baud, and J M Scherrmann
April 1992, Journal of clinical psychopharmacology,
G Ferron, and M Debray, and F Buneaux, and F J Baud, and J M Scherrmann
November 2003, European journal of clinical pharmacology,
G Ferron, and M Debray, and F Buneaux, and F J Baud, and J M Scherrmann
April 1991, Pharmacology & toxicology,
G Ferron, and M Debray, and F Buneaux, and F J Baud, and J M Scherrmann
January 1998, Magnetic resonance imaging,
G Ferron, and M Debray, and F Buneaux, and F J Baud, and J M Scherrmann
January 1979, Journal of psychiatric research,
G Ferron, and M Debray, and F Buneaux, and F J Baud, and J M Scherrmann
January 1997, Pharmacotherapy,
G Ferron, and M Debray, and F Buneaux, and F J Baud, and J M Scherrmann
January 1975, Activitas nervosa superior,
G Ferron, and M Debray, and F Buneaux, and F J Baud, and J M Scherrmann
February 1979, No to shinkei = Brain and nerve,
G Ferron, and M Debray, and F Buneaux, and F J Baud, and J M Scherrmann
July 1976, Acta pharmacologica et toxicologica,
Copied contents to your clipboard!